Head-to-head · WeighScore
EdgeRx vs WeightRx
The verdict
EdgeRx takes it — 79/100 to 72.1/100.
EdgeRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A men's-only compounded GLP-1 program that names its pharmacy (Strive Pharmacy, 503A since 2018) and its Chief Medical Advisor — real transparency signals most compounders skip.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | EdgeRx | WeightRx |
|---|---|---|
| WeighScore | 79/100 | 72.1/100 |
| Grade | C+ | C |
| Scorecard rank | #41 | #83 |
| Semaglutide | $229/mo | $250/mo (compounded) |
| Tirzepatide | $299/mo | $83/mo (term not published, compounded) |
| Coverage | 46 states (excludes Arkansas, Indiana, Minnesota, South Carolina) | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #41 · C+
Strengths
- Named compounding pharmacy — Strive Pharmacy, a 503A facility compounding since 2018 — a genuine transparency signal most compounders lack
- Named Chief Medical Advisor, Dr. John Starke, MD (ABEM board-certified)
- LegitScript certified, once-weekly injectable, free shipping, no separate physician fee
- Broad protocol menu beyond GLP-1 — MICC lipotropic, sermorelin/NAD+/glutathione, skin/hair, and sexual/hormonal health tiers
Where it loses points
- Men's-only positioning — not an option for women
- Dr. Starke does not personally prescribe; the actual prescribing pool is unnamed licensed physicians
- Third-party lab testing is claimed but no specific lab is named
- Excludes Arkansas, Indiana, Minnesota and South Carolina (46 states)
- Bloodwork cost is undisclosed on the Sexual & Hormonal Health tier
Graded #83 · C
Strengths
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
Where it loses points
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
- Six- and twelve-month plans are non-refundable, and eligible refunds carry a 5% processing fee
- No dose strength is published anywhere, so what the $83 buys is not stated
- The named operator is Twist G Marketing, LLC rather than a clinical entity, and the terms carry a binding arbitration and class-action waiver
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 509 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.